GE Healthcare is a leading global medical technology and digital solutions innovator. GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, diagnostic pharmaceuticals, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world. Follow us on Facebook, LinkedIn, Twitter and Insights or visit our website www.gehealthcare.com for more information.
PerkinElmer is a global company focused on improving the health and safety of people and their environment. Within the field of fetal and maternal healthcare, PerkinElmer offers complete screening solutions including instrumentation, reagents and risk calculation software for early detection of pre-eclampsia and pregnancy related anomalies.
PerkinElmer was chosen as the principal screening partner for ASPRE study. Throughout the study, the PerkinElmer DELFIA® Xpress PlGF 1-2-3TM assay was used as an aid in screening for pre-eclampsia in conjunction with maternal history, mean arterial blood pressure (MAP) measurement, and uAD (Uterine Artery Doppler). The study provided evidence that combined screening model is effective to identify women at high risk for preterm pre-eclampsia.
To help facilitate wider access to non-invasive prenatal testing for pregnant women, PerkinElmer offers an easy to use, cost-effective, high-throughput screening test. The Vanadis® NIPT system is an automated non-sequencing, non-PCR based solution for cfDNA analysis.
astraia software gmbh provides software solutions in obstetrics and gynaecology for structured documentation and reporting, as well as for scientific studies. The company was founded in 2000 and is based in Ismaning (Munich), Germany. A dedicated team of about 30 employees serves more than 1,700 customers in over 75 countries. In many countries, astraia is also represented by local sales partners.
We are supported by leading experts from all over the world to guarantee a comprehensive, practical and efficient documentation of the examinations with advanced medical functionalities, based on the latest knowledge and standardized terminology in around 20 languages.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche Sequencing Solution of Roche is focused on developing novel technologies and products to support innovation in clinical research applications. Part of Roche Sequencing Solutions, the Harmony® prenatal test is a non-invasive screening test for pregnant women that can be used as early as 10 weeks of pregnancy. By evaluating fetal cell-free DNA found in maternal blood, including accurate measurement of the fetal fraction of cfDNA, the test assesses the probability of Trisomy 21 (Down syndrome) and other common fetal chromosomal conditions. The results are intended for prenatal screening and are not intended to be the sole basis for diagnosis. The Harmony® prenatal test has been used to guide clinical care in over 1,400,000 pregnancies worldwide. For more information, visit www.harmonytest.com.
Philips is one of the world’s leading technology companies, with a long history of practical innovation and visionary design. In healthcare, we are committed to understanding the human and technological needs of patients and caregivers. We believe this understanding will help us deliver solutions that not only enable more confident diagnoses and more efficient delivery of care, but also improve the overall experience of care. We offer equipment, software, and services for imaging, patient monitoring, resuscitation and much more. Visit us at booth to learn more. People focused. Healthcare simplified.
Thermo Fisher Scientific
B·R·A·H·M·S GmbH, part of Thermo Fisher Scientific, investigates, develops and manufactures novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With high-quality immunodiagnostic tests for prenatal screening, cardiovascular, pulmonary, and cancer disorders as well as for sepsis, the company contributes to the creation of a healthier future – to the greatest advantage for medical professionals and patients.
In future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our know-how and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.
The B·R·A·H·M·S KRYPTOR platforms and the B·R·A·H·M·S biomarkers for prenatal screening are CE certified and approved by the Fetal Medicine Foundation (FMF), the portfolio comes up to the quality standards of the FMF since 1999.
Canon Medical Systems Europe
Canon Medical offers a full range of diagnostic medical imaging solutions including CT, MR, X-Ray, Ultrasound and Healthcare Informatics across the globe. In line with our Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.
At Canon Medical we work hand in hand with our partners – our medical, academic and research community. We build relationships based on transparency, trust and respect. Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life.
Sonio is an AI-software guiding practitioners during prenatal ultrasound scans to secure prenatal screening and optimize prenatal diagnosis.
Designed for prenatal diagnosis experts, Sonio Diagnostics combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis.
Suitable for all routine exams, Sonio Screening, assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitating the sharing of images with patients and other health professionals.